The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20080792: Sanmar Holdings Limited; ING Furman Selz Investors III L.P.
20080791: Shimano American Corporation; Nautilus, Inc.
20080782: Ares Corporate Opportunities Fund, L.P.; Hanger Orthopedic Group, Inc.
20080767: Banco de Sabadell, S.A.; Banco Bilbao Vizcaya Argentaria, S.A.
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.